Medivation Inc (NASDAQ:MDVN) announced that for the third year in a row it was named among the top mid-sized companies in the San Francisco …
Medivation Inc (NASDAQ:MDVN) announced that it has issued a notice of redemption to redeem on July 24, 2015 all of its outstanding 2.625% Convertible …
Medivation Inc (NASDAQ:MDVN) and Astellas announced that the first patients have been enrolled in TRUMPET (Treatment Registry for Outcomes in CRPC Patie nts), a …
Medivation (NASDAQ: MDVN) is best known for developing therapies to treat serious diseases. Earlier in 2014 the biopharmaceutical company received FDA approval to expand …
(Marketwired) – 11/06/14 – Medivation, Inc. (NASDAQ:MDVN) today reported its financial results for the third quarter ended September 30, 2014.
2014 has been an eventful year on Wall Street. Now that the year is coming to an end, what stocks should investors be …
Maxim Group analyst Jason Kolbert maintained a Buy rating on Medivation (NASDAQ:MDVN) and slightly raised his price target to $118 (from $112), as …
In a research report sent to investors today, Brean Capital analyst Jonathan Aschoff reaffirmed a Buy rating on Medivation (NASDAQ:MDVN) and increased his price …
In a research report published today, Wedbush analyst David Nierengarten reiterated an Outperfom rating on Medivation (NASDAQ:MDVN) with a $109 price target, ahead of the …
In a research report issued today, Canaccord analyst John Newman upgraded shares of Medivation (NASDAQ:MDVN) to Buy from Hold and doubled his price target to $132 …